NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,434 | +0.9% | 14,083 | 0.0% | 0.59% | +5.2% |
| Q2 2023 | $1,421 | +10.5% | 14,083 | +0.7% | 0.56% | +2.6% |
| Q1 2023 | $1,286 | +0.6% | 13,983 | -0.7% | 0.54% | -5.4% |
| Q4 2022 | $1,278 | -99.9% | 14,083 | 0.0% | 0.58% | +11.2% |
| Q3 2022 | $1,070,000 | -10.8% | 14,083 | -0.7% | 0.52% | -3.2% |
| Q2 2022 | $1,199,000 | -3.8% | 14,183 | -0.2% | 0.53% | +12.2% |
| Q1 2022 | $1,247,000 | -1.9% | 14,208 | -2.2% | 0.48% | +1.3% |
| Q4 2021 | $1,271,000 | +3.2% | 14,533 | -3.5% | 0.47% | -5.8% |
| Q3 2021 | $1,231,000 | -12.1% | 15,058 | -2.0% | 0.50% | -13.2% |
| Q2 2021 | $1,401,000 | +2.8% | 15,358 | -3.7% | 0.58% | -1.5% |
| Q1 2021 | $1,363,000 | +7.5% | 15,943 | +18.7% | 0.58% | -4.6% |
| Q4 2020 | $1,268,000 | +6.4% | 13,433 | -2.0% | 0.61% | +2.9% |
| Q3 2020 | $1,192,000 | +4.7% | 13,710 | +5.2% | 0.60% | -5.4% |
| Q2 2020 | $1,138,000 | +6.8% | 13,032 | +0.8% | 0.63% | -14.2% |
| Q1 2020 | $1,066,000 | -14.9% | 12,929 | -2.3% | 0.73% | +8.1% |
| Q4 2019 | $1,253,000 | +8.2% | 13,229 | -0.8% | 0.68% | +2.4% |
| Q3 2019 | $1,158,000 | -3.4% | 13,329 | +1.5% | 0.66% | -6.2% |
| Q2 2019 | $1,199,000 | -25.1% | 13,129 | -21.2% | 0.71% | -29.0% |
| Q1 2019 | $1,601,000 | +11.3% | 16,654 | -0.6% | 1.00% | -4.8% |
| Q4 2018 | $1,438,000 | +26.6% | 16,754 | +27.1% | 1.04% | +33.8% |
| Q3 2018 | $1,136,000 | +12.4% | 13,179 | -1.5% | 0.78% | +3.2% |
| Q2 2018 | $1,011,000 | -8.4% | 13,379 | -1.5% | 0.76% | -13.6% |
| Q1 2018 | $1,104,000 | -18.2% | 13,583 | -15.5% | 0.88% | -15.0% |
| Q4 2017 | $1,350,000 | -2.2% | 16,083 | 0.0% | 1.03% | -8.8% |
| Q3 2017 | $1,381,000 | +2.9% | 16,083 | 0.0% | 1.13% | -0.6% |
| Q2 2017 | $1,342,000 | +8.9% | 16,083 | -3.0% | 1.14% | +6.9% |
| Q1 2017 | $1,232,000 | -0.2% | 16,583 | +11.4% | 1.06% | +4.9% |
| Q4 2016 | $1,234,000 | -2.5% | 14,883 | -7.2% | 1.01% | -4.0% |
| Q3 2016 | $1,265,000 | +2.7% | 16,033 | +7.4% | 1.06% | -2.1% |
| Q2 2016 | $1,232,000 | +20.3% | 14,933 | +5.7% | 1.08% | +16.4% |
| Q1 2016 | $1,024,000 | +10.7% | 14,133 | +31.5% | 0.93% | +8.4% |
| Q4 2015 | $925,000 | – | 10,750 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |